In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CFSAN priorities

This article was originally published in The Rose Sheet

Executive Summary

CFSAN will hold a briefing with the press on May 3 at 2:30 p.m. to discuss its FY 2004 priority list, FDA announces. Phthalates and titanium dioxide are highlighted as priorities for the Office of Cosmetics & Colors. Cosmetic ingredient labeling also is included. Separately, while FDA plans to propose an updated ingredient regulation, the agency has not committed to recognizing the adopted and INCI names in the 10th edition of the Cosmetic, Toiletry and Fragrance Association's International Cosmetic Ingredient Dictionary, as reported in "The Rose Sheet" April 26, 2004, p. 3. Current regulation references the 2nd edition of the dictionary, among other sources...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS012087

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel